1985
DOI: 10.1016/s0040-4039(00)89169-8
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a bicyclic dipeptide with the shape of β-turn central part

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
66
0
3

Year Published

1993
1993
2010
2010

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 152 publications
(71 citation statements)
references
References 9 publications
2
66
0
3
Order By: Relevance
“…1). ␤-Turn mimics 1, 4, and 6 were designed to replace the i ϩ 1 and i ϩ 2 residues of a type IIЈ ␤-turn and were anticipated to match the right-handed twist of Pin WW (21,25). Compound 1 has reduced conformational freedom relative to 4 and 6.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…1). ␤-Turn mimics 1, 4, and 6 were designed to replace the i ϩ 1 and i ϩ 2 residues of a type IIЈ ␤-turn and were anticipated to match the right-handed twist of Pin WW (21,25). Compound 1 has reduced conformational freedom relative to 4 and 6.…”
Section: Resultsmentioning
confidence: 99%
“…1) (15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26). For the purpose of this paper, ␤-turn mimics are defined as molecules that replace the i ϩ 1 and i ϩ 2 amino acid residues of a ␤-turn.…”
mentioning
confidence: 99%
“…With chemical synthesis, virtually any conceivable covalent modification can be introduced at will anywhere in the protein molecule. An early example of the utility of this approach was the total chemical synthesis of (BTD) HIV-1 protease (87), a protein in which the Gly-Gly sequence found in a β-turn in the native protein (20) was replaced by the sterically constrained bicyclic compound BTD, a rigid mimetic of type II β-turn geometry (88). The resulting enzyme showed full activity and a significantly enhanced thermostability (87).…”
Section: Precise Covalent Modificationmentioning
confidence: 99%
“…BTD (bicyclic turn dipeptide: (3S,6S,9R)-2-oxo-3-t-butyloxycarboxylamino-7-thia-l-aza-bicyclo[4.3.0]nonane-9-carboxylic acid) (Fig. l), a rigid bicyclic &turn analog mimicking a type 11' P-turn (Nagai & Sato, 1985;Osano et al, 1989), was incorporated into the polypeptide in place of residues GlyI6-GlyI7 in the HIV-1 protease monomer sequence (Fig. 2).…”
Section: Protein Synthesismentioning
confidence: 99%